Introduction
This document provides technical specifications and clinical insights into the Tango® Neo laser system, developed by Ellex Medical Pty Ltd, a part of Lumibird Medical. It highlights the system's capabilities in treating glaucoma and secondary cataracts using Selective Laser Trabeculoplasty (SLT) and Nd:YAG laser modes.

Specifications
SLT Mode:
- Laser Source: Q-switched, frequency doubled Nd:YAG
- Wavelength: 532 nm
- Energy: 0.3 to 2.6 mJ per pulse, continuously variable
- Pulse Width: 3 ns
- Spot Size: 400 μm
- Aiming Beam: Red 635 nm, adjustable intensity

YAG Mode:
- Laser Source: Q-switched Nd:YAG
- Wavelength: 1064 nm
- Energy: 0.3 to 10 mJ per pulse, continuously variable
- Pulse Width: 4 ns
- Spot Size: 8 μm
- Offset: 0, -500 to +500 μm
- Aiming Beam: Red 635 nm adjustable intensity

Common Features:
- Repetition Rate: Up to 3 Hertz
- Magnification: Enhanced anterior segment visualization
- Illumination: Halogen
- Cooling: Air cooled
- User Interface: Capacitive 10.1” touch screen tablet
- Electrical Requirements: 100–240 VAC, 50/60 Hz, 800 VA
- Weight: 31 kg, 68 lbs (laser only)
- Dimensions: 57 x 75 x 44 cm, 23 x 30 x 18 inches (laser only)

Clinical Efficacy
The Tango® Neo system is clinically proven for treating Primary Open Angle Glaucoma and ocular hypertension. It offers a repeatable treatment option that eradicates compliance issues associated with medication. The system's SLT technology provides superior energy control and a homogenous aiming beam.

Key Treatment Modalities
- SLT Glaucoma Treatment
- YAG Posterior Capsulotomy
- Laser Peripheral Iridotomy

Clinical Study Insights
The LiGHT trial compared SLT with eye drops for treating ocular hypertension and glaucoma. Results showed that 74.2% of SLT patients reached target intraocular pressure (IOP) and were drop-free at 36 months, with five times fewer medication-related adverse events compared to eye drops.

Conclusion
The Tango® Neo laser system offers ophthalmologists a versatile tool for treating glaucoma and secondary cataracts with precision and efficiency. Its advanced features and clinical efficacy make it a valuable asset in delivering excellent patient outcomes globally.